Sartorius Stedim Biotech S.A.

SDMHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$219$401$1,130$647
Dep. & Amort.$302$238$182$142
Deferred Tax$0$0$0-$1
Stock-Based Comp.$0$0$0$1
Change in WC$251$191-$351-$146
Other Non-Cash$43-$83-$349$53
Operating Cash Flow$815$746$612$696
Investing Activities
PP&E Inv.-$340-$474-$431-$324
Net Acquisitions$0-$2,241-$516-$142
Inv. Purchases-$0$0$0-$324
Inv. Sales/Matur.$0$0$0$324
Other Inv. Act.-$0-$8-$11$0
Investing Cash Flow-$340-$2,723-$958-$465
Financing Activities
Debt Repay.-$862$2,323$392-$6
Stock Issued$1,194$1$0$0
Stock Repurch.-$2$0-$3$0
Dividends Paid-$67-$133-$116-$63
Other Fin. Act.-$178-$205-$52-$10
Financing Cash Flow$85$1,986$221-$72
Forex Effect$2-$0$8$5
Net Chg. in Cash$562$10-$117$164
Supplemental Information
Beg. Cash$117$107$224$60
End Cash$679$117$107$224
Free Cash Flow$475$273$182$372
Sartorius Stedim Biotech S.A. (SDMHF) Financial Statements & Key Stats | AlphaPilot